Understand CPT® ESWL and Ureteroscopic Stone Treatment Coding
Do you need modifier 53 for an ESWL converted to surgical treatment? Urinary stone disease (urolithiasis) is among the most common conditions urologists treat, affecting millions of patients annually. Extracorporeal shock wave lithotripsy (ESWL) and ureteroscopic stone treatment are the primary options for treating most renal and ureteral calculi (stones). While both procedures share the goal of eliminating urinary stones, they differ significantly in technique, clinical application, and CPT® code assignment. Understanding these differences and knowing how to code situations in which an ESWL procedure is converted to ureteroscopy is essential for accurate reporting, compliance, and appropriate reimbursement. Learn About Extracorporeal Shock Wave Lithotripsy ESWL is a noninvasive procedure that fragments urinary calculi using externally generated high-energy shock waves. The patient is positioned on a lithotripter, and the stone is localized using fluoroscopy or ultrasound. Once the stone is identified, shock waves are focused on the calculus, causing it to fracture into smaller fragments that can be naturally passed through the urinary tract. The appropriate CPT® code is 50590 (Lithotripsy, extracorporeal shock wave). Code 50590 represents the complete physician service for performing ESWL and is reported once per treatment session regardless of the number of shock waves delivered or the imaging modality used for stone localization. The code includes the physician work associated with positioning the patient, localizing the stone, administering the treatment, and assessing stone fragmentation during the procedure. You’ll usually select ESWL for renal stones and proximal ureteral stones, particularly those measuring less than 2 cm in diameter. Recovery is generally quicker than with surgical intervention, although repeat treatments may be necessary if complete fragmentation is not achieved. Understand How to Code Ureteroscopic Stone Treatment Ureteroscopy is a minimally invasive endoscopic procedure that allows direct visualization and treatment of stones within the ureter or kidney. A rigid or flexible ureteroscope is advanced through the urethra and bladder into the ureter or renal collecting system. Depending on the stone characteristics, the surgeon may either remove the stone intact using a basket or forceps, or treat the stone with ureteroscopy and laser lithotripsy. The urologist may also insert a ureteral stent to keep the ureter open, allow the stone fragments to pass, and help the ureter to heal. The most common codes for ureteral stone treatment are: Report 52352 when the surgeon removes the stone intact using a basket or forceps or manipulates it without fragmentation. Assign 52353 when the provider performs a cystourethroscopy through the urethra to inspect the interior of the bladder, the urethra, prostatic urethra, and ureteric openings, and then uses a ureteroscope to inspect the ureter(s). The physician may also use a pyeloscopy to perform an inspection of the renal pelvis. When the urologist finds a calculus, they use lithotripsy with a holmium or thulium fiber laser to break up the stone so the fragments can pass or be washed out with irrigation. Ureteroscopy is frequently chosen for distal ureteral stones, impacted calculi, larger stone burdens, or patients who are not ideal candidates for ESWL. Flexible ureteroscopy also allows treatment of stones located throughout the renal collecting system. Use 52356 when the urologist performs the same procedure as 52353 using a cystoscopy to inspect the bladder, the urethra, prostatic urethra, etc.; but then after the stone is fragmented using the laser lithotripsy, the physician inserts an indwelling ureteral stent to keep the ureter open for passage of fragments and allow it to heal. If the surgeon performed stone treatment on the right and left kidneys, consider appending modifier 50 (Bilateral procedure) or the RT (Right side) and LT (Left side) modifiers for right and left kidneys. Remember These Documentation Tips When Coding Urinary Stone Treatments As a urology coder, you know that assigning the correct codes is only part of the coding process. Another equally important step is ensuring the documentation contains the necessary information to select the codes. ESWL operative documentation should include: Ureteroscopy operative documentation should include: Code the Converted Procedure One of the more common coding questions arises when a patient is scheduled for ESWL but ultimately undergoes ureteroscopic stone treatment during the same operative session. Proper coding depends on what was actually performed, not the physician’s original intent. Know What to do When a Planned ESWL Isn’t Performed Occasionally, after anesthesia is administered and imaging is obtained, the physician determines that ESWL cannot be performed. Common reasons include inability to adequately visualize the stone, unexpected stone migration, patient positioning difficulties, or other clinical findings that make ESWL ineffective or inappropriate. The surgeon may then proceed directly to ureteroscopy. In these situations, you won’t report 50590 because the provider did not perform the therapeutic ESWL service. Instead, report only the definitive ureteroscopic procedure, such as: The preoperative intent to perform ESWL does not create a separately billable service. Code an Initiated ESWL That’s Converted to Ureteroscopy In some cases, the physician begins ESWL and delivers shock waves but determines that fragmentation is inadequate or impossible during the procedure. The stone may migrate or fail to fragment, or other circumstances may prompt immediate conversion to ureteroscopy during the same operative session. From a physician coding perspective, the definitive ureteroscopic procedure is generally the reportable service. In most cases, you should only report 52352, 52353, or 52356 because the ureteroscopic intervention successfully accomplished the therapeutic objective. Although shock waves may have been delivered, the incomplete ESWL is generally considered part of the overall treatment episode rather than a separately reportable procedure. Typically, modifier 53 (Discontinued procedure) is not appropriate simply because the physician elected to convert to a more effective treatment. Modifier 53 is intended for procedures discontinued because of extenuating circumstances or concerns for patient safety, not because a different therapeutic approach was selected. Because payer policies may vary, coders should always review National Correct Coding Initiative (NCCI) edits, Medicare Administrative Contractor (MAC) guidance, and commercial payer policies before reporting both procedures. Conclusion ESWL and ureteroscopic stone treatment remain the cornerstone therapies for urinary stone disease, each offering distinct clinical advantages depending on stone size, location, and patient characteristics. When a procedure is converted to another treatment, coders should remember the fundamental CPT® principle: Report the definitive procedure that the provider actually performed. Thorough documentation, familiarity with CPT® guidelines, and awareness of payer-specific policies will help ensure compliant coding and appropriate reimbursement while accurately reflecting the physician’s work. Stephanie N. Stinchcomb Storck, CPC, CPMA, CUC, CCS-P,
longtime urology coding expert, Summerfield, Florida
